Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis

This publication has 44 references indexed in Scilit:

• Nasal boost with adjuvanted heat-killed BCG or arabinomannan–protein conjugate improves primary BCG-induced protection in C57BL/6 mice
  Tuberculosis, 2005
• Vaccination of neonatal calves withMycobacterium bovisBCG induces protection against intranasal challenge with virulentM. bovis
  Clinical and Experimental Immunology, 2004
• A DNA Prime- Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine Tuberculosis
  Infection and Immunity, 2003
• A review of tuberculosis: reflections on the past, present and future of a global epidemic disease
  Expert Review of Anti-infective Therapy, 2003
• Oral Delivery ofMycobacterium bovisBCG in a Lipid Formulation Induces Resistance to Pulmonary Tuberculosis in Mice
  Infection and Immunity, 2003
• Tuberculosis in free-ranging wildlife: detection, diagnosis and management
  Revue Scientifique et Technique de l'OIE, 2002
• Intranasal BCG vaccination protects BALB/c mice against virulentMycobacterium bovisand accelerates production of IFN-γ in their lungs
  Clinical and Experimental Immunology, 2001
• Tuberculosis vaccine development: recent progress
  Trends in Microbiology, 2001
• Enhanced Immunogenicity of CD4⁺T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis
  Infection and Immunity, 2001
• Differential Protective Efficacy of DNA Vaccines Expressing Secreted Proteins ofMycobacterium tuberculosis
  Infection and Immunity, 1999